Literature DB >> 24115183

Voice quality after treatment of T1a glottic cancer.

Samia Laoufi1, Haïtham Mirghani, François Janot, Dana M Hartl.   

Abstract

OBJECTIVES/HYPOTHESIS: To compare voice handicap and quality of life after radiotherapy (RT) versus transoral laser surgery (LS) for T1a glottic carcinoma. STUDY
DESIGN: Retrospective study (1996-2011) of patients treated with RT or LS for T1a glottic squamous cell carcinoma with curative intent.
METHODS: Disease-free patients were assessed using Voice Handicap Index (VHI 30) and European Organization for Research and Treatment of Cancer Head and Neck Quality of Life (EORTC QLQ-HN35) questionnaires.
RESULTS: Of 147 patients, 95 (65%) completed the questionnaires: fifty-one patients an average of 8 years after RT and 44 patients an average of 4 years after LS (no difference in age or sex ratio). The average total VHI 30 was 13.1 for RT and 29.2 for LS (P < .0001), with average emotional, physical and functional subscores significantly different. The average total EORTC QLQ-HN35 was 37.7 for RT versus 40.7 for LS (P = .7), with a difference only in the speaking subscore (P = .04).
CONCLUSIONS: Long-term subjective voice-related quality of life was worse after LS, with no difference in other domains. These results should be interpreted in light of the biases inherent in retrospective studies. LEVEL OF EVIDENCE: 4.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Glottic cancer; laser; quality of life; radiotherapy; squamous cell carcinoma; voice handicap

Mesh:

Year:  2013        PMID: 24115183     DOI: 10.1002/lary.24445

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.

Authors:  William M Mendenhall; Robert P Takes; Jatin P Shah; Patrick J Bradley; Jonathan J Beitler; Primož Strojan; Carlos Suárez; Juan P Rodrigo; Nabil F Saba; Alessandra Rinaldo; Jochen A Werner; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-08       Impact factor: 2.503

2.  Change in Voice Quality after Radiotherapy for Early Glottic Cancer.

Authors:  Jana Mekiš; Primož Strojan; Dušan Mekiš; Irena Hočevar Boltežar
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

3.  Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx.

Authors:  Philippe Gorphe; Pierre Blanchard; Stephane Temam; François Janot
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-14       Impact factor: 2.503

4.  Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer.

Authors:  Nicola Lombardo; Teodoro Aragona; Said Alsayyad; Girolamo Pelaia; Rosa Terracciano; Rocco Savino
Journal:  Lasers Med Sci       Date:  2017-10-26       Impact factor: 3.161

5.  Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.

Authors:  Seung Yeun Chung; Kyung Hwan Kim; Ki Chang Keum; Yoon Woo Koh; Se-Heon Kim; Eun Chang Choi; Chang Geol Lee
Journal:  Cancer Res Treat       Date:  2017-03-17       Impact factor: 4.679

6.  Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: A systematic review and meta-analysis.

Authors:  André Vicente Guimarães; Rogério Aparecido Dedivitis; Leandro Luongo Matos; Felipe Toyama Aires; Claudio Roberto Cernea
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

7.  T1a Glottic Cancer: Advances in Vocal Outcome Assessment after Transoral CO2-Laser Microsurgery Using the VEM.

Authors:  Wen Song; Felix Caffier; Tadeus Nawka; Tatiana Ermakova; Alexios Martin; Dirk Mürbe; Philipp P Caffier
Journal:  J Clin Med       Date:  2021-03-17       Impact factor: 4.241

8.  Oncological and functional outcomes following treatment of T1a glottic squamous cell carcinoma with transoral laser microsurgery.

Authors:  Dennis E Curry; David Forner; Matthew H Rigby; Jonathan R Trites; Martin Corsten; S Mark Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.